Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2002
11/13/2002CN1379669A Valdecoxib compositions
11/12/2002US6479627 Aqueous preparation of lactoferrin having improved stability
11/12/2002US6479556 Adding polyoxyethylene sorbitan ester to an ophthalmic formulation containing a terpenoid such as camphor, borneol, and menthol to improve wettability
11/12/2002US6479544 Therapeutic combinations of fatty acids
11/12/2002US6479530 Substituted 4(5)-(1-indanyl,-indanylmethyl, indanylmethylen), 4(5)-(1-(1,2,3,4-tetrahydronaphthyl, -naphthylmethyl and naphthylmethylen)imidazoles; hypotensive, ischemic and anxiolytic agents; nervous and muscular system disorders
11/12/2002US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002US6479512 Tyrosine kinase inhibitors
11/12/2002US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002US6479481 Administering an effective dose of a cns tumor-inhibiting methylol transfer agent such as: taurolidine, taurultam or a mixture thereof.
11/12/2002US6479458 Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
11/07/2002WO2002088664A2 Control of compactability through crystallization
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002WO2002088123A1 Chemical compounds
11/07/2002WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002WO2002088111A1 Novel benzylpiperidine compound
11/07/2002WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002WO2002087595A1 Treating retinal or photoreceptor degenerative diseases
11/07/2002WO2002087586A1 Sustained release drug delivery system containing codrugs
11/07/2002WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002WO2002087563A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002WO2002087557A1 Method for treating retina or photoreceptor degeneration
11/07/2002WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002WO2002087326A1 Compositions including vitamin-based surfactants ad methods for using same
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2002056827A3 Substituted felbamate derived compounds
11/07/2002WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002WO2002040030A8 Combination therapy for lowering and controlling intraocular pressure
11/07/2002WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002WO2001091765A3 Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002WO2000064420A3 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/07/2002US20020165522 Method for use in cataract surgery
11/07/2002US20020165374 Secreted protein HFEAF41
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165268 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
11/07/2002US20020165254 Autoclavable pharmaceutical compositions containing a chelating agent
11/07/2002US20020165247 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020164734 Human pelota homolog
11/07/2002US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002CA2446491A1 Compositions including vitamin-based surfactants ad methods for using same
11/07/2002CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002CA2445763A1 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002CA2445702A1 Control of compactability through crystallization
11/07/2002CA2445348A1 Novel benzylpiperidine compound
11/07/2002CA2445338A1 G-protein coupled receptors
11/07/2002CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002CA2445290A1 A pharmaceutical tablet having a high api content
11/06/2002EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002EP1254664A2 Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans
11/06/2002EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002EP1254236A2 Drug metabolizing enzymes
11/06/2002EP1254235A2 Drug metabolizing enzymes
11/06/2002EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002EP1254133A2 Indol-3-yl derivatives
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002EP1254112A2 Ocular hypotensive lipids
11/06/2002EP1253948A2 Gene therapy for treating ocular-related disorders
11/06/2002EP1253943A2 Photodynamic therapy for treating conditions of the eye
11/06/2002EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002EP1253917A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
11/06/2002EP1173207B1 Miotic agents and hypertonic agents containing ophthalmic compositions
11/06/2002EP1107731B1 Synthetic tear fluid
11/06/2002EP1037622A4 Taurine derivatives usable in the treatment of ophthalmic disorders
11/06/2002EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002EP0901373B1 Alpha v Beta 3 ANTAGONISTS
11/06/2002CN1378554A Novel fusidic acid derivatives
11/06/2002CN1378546A Antibiotic sultam and sultone drived oxazolidiones
11/06/2002CN1378544A Substituted azoles compounds
11/06/2002CN1378543A Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
11/06/2002CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
11/06/2002CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002CN1377706A Ocular in-situ gel preparatino with proper phase conversion temperature
11/06/2002CN1377700A Medicine for curing otitis media and its preparing method
11/06/2002CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
11/05/2002US6476195 Secreted protein HNFGF20
11/05/2002US6476064 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
11/05/2002US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002US6476039 Acylurea containing quinazoline derivatives
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 531